Rocío Blanco, MD 🇦🇷 (@_RoBlanco) header
Rocío Blanco, MD 🇦🇷 (@_RoBlanco) profile picture

Cardiologa. Multi-imágenes en cardiología @imedCV. Miocardiopatias, cardiopatías familiares y 🫀🧬 @cardiogenSAC

Buenos Aires
Joined September 2020
Photo by Rocío Blanco, MD 🇦🇷 (@_RoBlanco)Photo by Rocío Blanco, MD 🇦🇷 (@_RoBlanco)Photo by Rocío Blanco, MD 🇦🇷 (@_RoBlanco)Photo by Rocío Blanco, MD 🇦🇷 (@_RoBlanco)Photo by Rocío Blanco, MD 🇦🇷 (@_RoBlanco)Photo by Rocío Blanco, MD 🇦🇷 (@_RoBlanco)Photo by Rocío Blanco, MD 🇦🇷 (@_RoBlanco)Photo by Rocío Blanco, MD 🇦🇷 (@_RoBlanco)Photo by Rocío Blanco, MD 🇦🇷 (@_RoBlanco)Photo by Rocío Blanco, MD 🇦🇷 (@_RoBlanco)
Rocío Blanco, MD 🇦🇷 retweeted
In hypertrophic cardiomyopathy genetics, “negative” has an expiry date. Updated panels uncover new answers, from ALPK3 and FHOD3 to deep intronic MYBPC3. Read more in #EHJ. doi.org/10.1093/eurheartj/eh… #cardiomyopathy #cardiotwitter @ESC_Journals @escardio
22
2
75
7,073
Rocío Blanco, MD 🇦🇷 retweeted
Nuestro trabajo sobre el valor pronóstico de la FEVD por RMC en CA-TTR está online en @CurrProbsCardio Un trabajo liderado por @Florcantora_ que comenzó con su presentación como abstract en @SAC_54 ✅ y completa el camino con una publicación internacional 🌎 ¡Felicitaciones!
2
1
10
242
Rocío Blanco, MD 🇦🇷 retweeted
Our findings suggest a disruption of the PD-L1/PD-1 axis in lymphocytic acute myocarditis, representing a potential target for future therapies. @CardioOncology @EricAdler17 jacc.org/doi/10.1016/j.jacad…
8
21
1,528
Rocío Blanco, MD 🇦🇷 retweeted
New publication in JACC: Case Reports: Recurrent cardiac myxomas in Carney complex. This case highlights the importance of early recognition, multimodality imaging, and lifelong multidisciplinary follow-up in CNC. @JACCJournals @imedCV @cardiohiba_resi @ManuChiodi @_RoBlanco
4
1
10
252
Rocío Blanco, MD 🇦🇷 retweeted
Optimizing Screening Intervals for At-Risk Relatives of Dilated Cardiomyopathy Carrying a TTNtv @FatkinLab @AChristensen112 @Dr_Pavia @ulvedreng @fernidom @ERNGUARDHeart @Ellenbroek ahajrnls.org/4xUupD2
4
11
687
Rocío Blanco, MD 🇦🇷 retweeted
🫀☕ Café con expertos | CUORE 26 Un espacio de encuentro para compartir experiencias, intercambiar conocimientos y conversar sobre casos clínicos junto a especialistas. 📅 13 de octubre 📍 Hilton BA | Puerto Madero ¡Los esperamos! #CUORE26 #Cardiología #CaféExpertos #HIBA
4
6
201
Rocío Blanco, MD 🇦🇷 retweeted
Gene editing isn't just science fiction anymore - it's moving into cardiovascular care. See the official ACC scientific statement to see where the field stands and what it means for the future of heart disease treatment jacc.org/doi/10.1016/j.jacc.… #JACC #cvGenetics #GeneEditing #CVD
1
9
29
4,624
Rocío Blanco, MD 🇦🇷 retweeted
🆕 SIMPOSIO MUERTE SÚBITA 🔗 Inscribite a través del link de nuestro perfil o us02web.zoom.us/meeting/regi… ¡Te esperamos! #imedcv #muertesubita #argenetics #hiba
1
3
155
Rocío Blanco, MD 🇦🇷 retweeted
Should we rethink genetic testing in older #DCM patients?🧬 In this cohort of 686 patients: 📍median age 50, 62.1% male 📍1 in 5 patients over 55 years of age were genotype-positive 📍30% of genotype-positive patients >55 years had high-risk genotypes 📍Similar risk of ventricular arrhythmias & end-stage HF vs younger patients 📚Read more in #EJHF @EJHFEiC :
doi.org/10.1093/ejhf/xuag055 #HeartFailure #Cardiomyopathy #Genetics @escardio @MarcoMetra @dougcannie @ath_bakalakos @ESC_Journals
18
36
2,155
Rocío Blanco, MD 🇦🇷 retweeted
The last 10 years have truly revolutionized our understanding of HCM and brought with it tremendous developments in new medicines Time to think beyond our historical simple assumptions This study nicely shows the need to adapt and sub-phenotype Asymptomatic HCM shouldn't only rely on symptoms. Evaluating MR/LA size/diastolic dysfunction, NTproBNP, and exercise induced PH allows one to truly phenotype this group further. jacc.org/doi/10.1016/j.jacc.… #CardioTwitter
19
79
6,305
Rocío Blanco, MD 🇦🇷 retweeted
🧬Precision medicine paradox: the more we stratify patients, more fragmented our datasets become In #rarediseases, this means overfitting, weak external validation & limited reproducibility Solution? Collaboration, shared standards & better biobanking 🌍🤝 thelancet.com/journals/landi…
8
1
15
887
Rocío Blanco, MD 🇦🇷 retweeted
🆕 Muy contento de compartir una nueva publicación de nuestro equipo 🙌 “The role of nutritional status, measured by serum albumin, as a prognostic factor in wild-type transthyretin amyloidosis” Los invito a leer el trabajo completo ⬇️ tandfonline.com/eprint/M9J7V…
2
3
11
211
Rocío Blanco, MD 🇦🇷 retweeted
🧬 Genetic testing in Dilated Cardiomyopathy: are we using it right? A new ESC consensus highlights a key shift: genetics in DCM is no longer just about family screening—it’s now central to clinical decision-making. 🔍 Key messages 🧠 Not just monogenic anymore DCM is increasingly seen as a continuum: Rare variants (high impact) common variants (polygenic background) environmental triggers ➡️ Disease = interaction, not a single mutation 🧬 Who should be tested? → almost everyone Genetic testing is recommended when results can impact: ✔️ diagnosis ✔️ prognosis ✔️ treatment (e.g. ICD decisions) ✔️ family screening ➡️ Even “acquired” DCM does NOT exclude genetics 📊 Yield is variable but meaningful ~8–36% overall up to 55% in familial DCM ➡️ Still clinically impactful despite imperfect yield ⚠️ Gene panels: bigger ≠ better Large panels increase VUS Limited gain in actionable variants ➡️ Focus on validated disease genes is key 🔥 Genotype matters clinically Some genes carry higher arrhythmic risk: LMNA, FLNC, DSP, RBM20, PLN ➡️ Can influence ICD decision-making beyond EF 🧩 The real paradigm shift: interpretation Genetic results must be read in context: phenotype environment (e.g. myocarditis, chemo, pregnancy) penetrance ➡️ A variant alone is NOT the diagnosis 👨‍👩‍👧 Family impact is huge Enables cascade screening Can discharge gene-negative relatives Opens reproductive options 💡 Take-home message Genetic testing in DCM is no longer optional or “nice to have”— it’s becoming a core part of precision cardiology. 👉 But its value depends entirely on how well we interpret it. #Cardiology #DCM #Genetics #Cardiomyopathy #PrecisionMedicine #HeartFailure #ESC #MedEd 🧬🫀 doi.org/10.1093/eurheartj/eh…
24
1
60
4,133
Rocío Blanco, MD 🇦🇷 retweeted
Ya está disponible un nuevo número de @revistarac 📖 Compartimos un interesante artículo liderado por @Florcantora_ acerca del valor pronóstico del SLG medido en #whycmr en pacientes con MCH seguidos en @imedCV 🫀 👇👇👇 rac.sac.org.ar/index.php/rac…
2
2
9
358
Rocío Blanco, MD 🇦🇷 retweeted
🧬Más del 30% de pacientes con #EnfermedadesRaras no llegan a conocer el diagnóstico genético de su enfermedad. Proyectos como #IMPaCT-Genómica han demostrado arrojar luz donde solo había sombras. Necesitamos integrar la genómica en la práctica clínica. lavozdegalicia.es/noticia/so…
10
22
616
Rocío Blanco, MD 🇦🇷 retweeted
🫀 Quimioterapia + mutación DSP + RMN con realce en anillo + CDI 👉 La QT como second hit en DSP Esto te mostramos en este caso que publicamos en #JACCCaseReports @JACCJournals junto a @_RoBlanco @G1FERNANDEZ @BroggerNoel jacc.org/doi/epdf/10.1016/j.…
3
5
2
11
889
Inauguramos temporada de ateneos en @cardiogenSAC " No todo es tan simple " ... explorando la arquitectura compleja de #HCM de la mano de @jpocardio @eduardo_oc12 @_RoBlanco
1
4
68
Rocío Blanco, MD 🇦🇷 retweeted
🥂The Seaport Criteria - a new histologic Standard to Diagnose Myocarditis - the Lake Louise criteria of histology to diagnose myocarditis sciencedirect.com/science/ar…
11
20
1,100
Rocío Blanco, MD 🇦🇷 retweeted
Miocardiopatía por TTN: expandiendo la relevancia clínica más allá de la banda A #REC. revespcardiol.org/es-miocard…
1
4
7
617